See a live demonstration of cell-based assays under dynamic shear flowFluid movement that applies force to cells and biofilms; used to mimic physiological/pathological conditions. conditions.
Hyperacute rejection remains a major obstacle in lung xenotransplantation, driven by human antibodies targeting glycan structures on porcine endothelial cells.
The discovery of high-quality antibodies is critical for both research and therapeutic development. However, identifying rare antibody-secreting cells from B cell or hybridoma populations remains challenging, slowing the discovery process and increasing the risk of missing valuable antibody candidates.
Over the past decade, tissue-specific 3D cell culture has emerged as a promising alternative to animal testing—delivering human relevant data by better mimicking in vivo conditions such as cellular diversity, metabolism, and drug response.
The discovery of high-quality antibodies is critical for both research and therapeutic development. However, identifying rare antibody-secreting cells from B cell or hybridoma populations remains challenging, slowing the discovery process and increasing the risk of missing valuable antibody candidates.
Over the past decade, tissue-specific 3D cell culture has emerged as a promising alternative to animal testing—delivering human relevant data by better mimicking in vivo conditions such as cellular diversity, metabolism, and drug response.
See a live demonstration of cell-based assays under dynamic shear flow conditions.
Hyperacute rejection remains a major obstacle in lung xenotransplantation, driven by human antibodies targeting glycan structures on porcine endothelial cells.
The discovery of high-quality antibodies is critical for both research and therapeutic development. However, identifying rare antibody-secreting cells from B cell or hybridoma populations remains challenging, slowing the discovery process and increasing the risk of missing valuable antibody candidates.
Over the past decade, tissue-specific 3D cell culture has emerged as a promising alternative to animal testing—delivering human relevant data by better mimicking in vivo conditions such as cellular diversity, metabolism, and drug response.
The discovery of high-quality antibodies is critical for both research and therapeutic development. However, identifying rare antibody-secreting cells from B cell or hybridoma populations remains challenging, slowing the discovery process and increasing the risk of missing valuable antibody candidates.
Over the past decade, tissue-specific 3D cell culture has emerged as a promising alternative to animal testing—delivering human relevant data by better mimicking in vivo conditions such as cellular diversity, metabolism, and drug response.
